| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Associated with increased circRNA/mRNA ratio in CRC predisposition cohort; described as having oncogenic potential. |
| Molecular mechanism: |
Not demonstrated in this study; authors report imbalance likely reflects increased circRNA production or accumulation rather than decreased host-gene mRNA, suggesting independent regulation. |
| Biological pathway or process: |
ceRNA regulation (other) |
| Detected method: |
S
|
| Validation methods: |
circRNA-seq; Bioinformatics Analysis; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; Clinical Sample Validation |
| Clinical significance: |
In blood, circRNA/mRNA imbalance in CRC patients was largely driven by circPOLD1(3,2), suggesting potential biomarker or functional contributor to cancer predisposition. |
| Description: |
In peripheral blood from patients suspected of hereditary CRC, circPOLD1(3,2) is implicated as the main driver of an increased circRNA/mRNA ratio (relative to controls). The study suggests the imbalance likely reflects increased circRNA production/accumulation rather than reduced POLD1 mRNA, and highlights circPOLD1(3,2) as a candidate biomarker or contributor to CRC predisposition. |
| Confidence score: |
0.5297 |